Table 1.
Characteristic | No recognition (N=23007) | CKD recognition (N=2735) | p value* |
---|---|---|---|
Age, yrs, mean (s.d.) | 70.9±12.3 | 68.4±13.8 | <0.0011 |
Female, n (%) | 14424(62.7) | 1069(39.1) | <0.001 |
Male, n (%) | 8583(37.3) | 1666(60.9) | |
Race, n (%) | <0.001 | ||
Caucasian | 20424(88.8) | 2098(76.7) | |
African American | 2227(9.7) | 583(21.3) | |
Other | 356(1.5) | 54(2.0) | |
Insurance, n (%); ** | <0.001 | ||
Medicare | 17462(77.3) | 2066(77.6) | |
Medicaid | 131(0.58) | 27(1.0) | |
Other | 4991(22.1) | 571(21.4) | |
Years of Outpatient follow up, mean (s.d.) | 4.6±1.6 | 4.5±1.8 | 0.040 |
Office Visits per year, mean (s.d.) | 6.3±4.7 | 7.7±5.7 | <0.0011 |
eGFR | 50.1±8.6 | 37.5±12.3 | <0.0011 |
CKD stages | <0.001 | ||
CKD Stage 3a | 17680(76.8) | 833(30.5) | |
CKD Stage 3b | 4572(19.9) | 1101(40.3) | |
CKD Stage 4 | 715(3.1) | 699(25.6) | |
CKD Stage 5 | 40(0.17) | 102(3.7) | |
eGFR at 1 year post confirmation | 52.6±11.7 | 37.0±14.2 | <0.0011 |
Comorbid Conditions | |||
Hypertension, Yes, n (%) | 20841(90.6) | 2558(93.5) | <0.001 |
Coronary Artery Disease, Yes, n (%) | 4317(18.8) | 683(25.0) | <0.001 |
Congestive Heart Failure, Yes, n (%) | 1292(5.6) | 271(9.9) | <0.001 |
Hyperlipidemia, Yes n (%) | 19154(83.3) | 2230(81.5) | 0.024 |
Cerebrovascular disease, (%) | 2042(8.9) | 325(11.9) | <0.001 |
Diabetes, Yes, n (%) | 5285(23.0) | 1096(40.1) | <0.001 |
Chi-Square
Insurance Missing, n=494
Equal Variance T-Test
CKD = chronic kidney disease; EHR = electronic health record; eGFR = estimated glomerular filtration rate; Other is non-Medicare/Medicaid health insurance